Chemotherapy in falciparum malaria resistant to quinine

Severe quinine-resistant malaria is exceptionally rare at present. It is currently (1997) a clinical problem in a very restricted area of Southeast Asia. Patients who come from the Thai-Burmese or Thai-Cambodian borders should be considered potentially to have quinine resistance, and alternative drugs should be considered. Resistance patterns change rapidly, and up-to-date information about them should be sought in these patients. Only artemisinine derivatives can reliably take the place of quinine for parenteral treatment, and currently these are available only on a named-patient basis in Europe and America. The alternatives are as follows.

1. Artesunate (as sodium artesunate) diluted in 5 to 10 ml of 5 per cent glucose by intravenous or intramuscular injection. The initial dose is 2.4 mg/kg, followed by 1.2 mg/kg at 12 and 24 h, and daily thereafter (Hie_D__aD_d__White 1993).

2. Artemether by intramuscular injection. The initial dose is 3.2 mg/kg, followed by 1.6 mg/kg daily.

Both should be followed by a second-line drug. Reports of increased incidence of neurotoxicity with mefloquine make other choices of second-line drugs, such as doxycycline, more attractive.

Where artemesinine derivatives are not available, combined therapy using quinine or quinidine as above with doxycycline up to 3 mg/kg/day will reduce failure rates in quinine resistance.

Healthy Fat Loss For A Longer Life

Healthy Fat Loss For A Longer Life

What will this book do for me? A growing number of books for laymen on the subject of health have appeared in the past decade. Never before has there been such widespread popular interest in medical science. Learn more within this guide today and download your copy now.

Get My Free Ebook


Post a comment